Baseline demographics and clinical characteristics (MRS analysis population).</p
<p>Demographics and clinical characteristics of matched patients at baseline.</p
Baseline demographics and treatment-related characteristics of study participants.</p
Patient demographics, baseline disease characteristics, and treatment (safety analysis population).<...
Demographic and clinical characteristics of the study population at baseline.</p
Baseline demographic data and clinical characteristics of the study population.</p
Baseline demographics and clinical characteristics (RadRS analysis population).</p
Demographics and baseline clinical characteristics of all study participants.</p
<p>The Demographics and Clinical Characteristics of the Baseline Participants.</p
Baseline characteristics and demographics of the entire population of fifty-two patients.</p
Baseline characteristics of the total study population and the sample used for analysis.</p
Participant demographic and disease characteristics at baseline (mITT population).</p
<p>Clinical, demographic and laboratory baseline characteristics of the study population.</p
<p>Baseline demographics and clinical characteristics of the study participants.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
Baseline demographic and clinical characteristics of the analytical cohort (n = 121,241).</p
<p>Demographics and clinical characteristics of matched patients at baseline.</p
Baseline demographics and treatment-related characteristics of study participants.</p
Patient demographics, baseline disease characteristics, and treatment (safety analysis population).<...
Demographic and clinical characteristics of the study population at baseline.</p
Baseline demographic data and clinical characteristics of the study population.</p
Baseline demographics and clinical characteristics (RadRS analysis population).</p
Demographics and baseline clinical characteristics of all study participants.</p
<p>The Demographics and Clinical Characteristics of the Baseline Participants.</p
Baseline characteristics and demographics of the entire population of fifty-two patients.</p
Baseline characteristics of the total study population and the sample used for analysis.</p
Participant demographic and disease characteristics at baseline (mITT population).</p
<p>Clinical, demographic and laboratory baseline characteristics of the study population.</p
<p>Baseline demographics and clinical characteristics of the study participants.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
Baseline demographic and clinical characteristics of the analytical cohort (n = 121,241).</p
<p>Demographics and clinical characteristics of matched patients at baseline.</p
Baseline demographics and treatment-related characteristics of study participants.</p
Patient demographics, baseline disease characteristics, and treatment (safety analysis population).<...